financetom
Business
financetom
/
Business
/
Silgan's Q1 Adjusted Earnings, Revenue Rise; Provides Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Silgan's Q1 Adjusted Earnings, Revenue Rise; Provides Guidance
May 25, 2025 9:51 PM

07:53 AM EDT, 04/30/2025 (MT Newswires) -- Silgan ( SLGN ) reported Q1 earnings Wednesday of $0.82 per diluted share, compared with $0.69 a year earlier.

Analysts surveyed by FactSet expected $0.79.

Revenue for the quarter ended March 31 was $1.47 billion, compared with $1.32 billion a year earlier.

Analysts surveyed by FactSet expected $1.47 billion.

The packaging company said it expects adjusted EPS to be in a range of $0.98 to $1.08 in Q2, and $4.00 to $4.20 for full-year 2025.

Analysts surveyed by FactSet expect Q2 and full-year 2025 adjusted EPS of $1.04 and $4.09, respectively.

Shares of Silgan ( SLGN ) were down 1.8% in recent premarket activity.

Price: 51.50, Change: -0.95, Percent Change: -1.81

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nvidia Insider Sold Shares Worth $31,557,278, According to a Recent SEC Filing
Nvidia Insider Sold Shares Worth $31,557,278, According to a Recent SEC Filing
Jun 24, 2024
03:17 AM EDT, 06/24/2024 (MT Newswires) -- Jen Hsun Huang, Director, President and Chief Executive Officer, on June 19, 2024, sold 240,000 shares in Nvidia ( NVDA ) for $31,557,278. Following the Form 4 filing with the SEC, Huang has control over a total of 261,911,115 shares of the company, with 80,694,995 shares held directly and 181,216,120 controlled indirectly. SEC...
Apellis Pharmaceuticals Insider Sold Shares Worth $1,451,835, According to a Recent SEC Filing
Apellis Pharmaceuticals Insider Sold Shares Worth $1,451,835, According to a Recent SEC Filing
Jun 24, 2024
03:21 AM EDT, 06/24/2024 (MT Newswires) -- A. Sinclair Dunlop, Director, on June 21, 2024, sold 37,000 shares in Apellis Pharmaceuticals ( APLS ) for $1,451,835. Following the Form 4 filing with the SEC, Dunlop has control over a total of 302,371 shares of the company, with 133,518 shares held directly and 168,853 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1492422/000095017024076423/xslF345X03/ownership.xml Price: 38.50,...
PepsiCo to waive clause in bottling deal as Carlsberg eyes $3.9 bln Britvic bid
PepsiCo to waive clause in bottling deal as Carlsberg eyes $3.9 bln Britvic bid
Jun 24, 2024
June 24 (Reuters) - Carlsberg said on Monday PepsiCo has agreed to waive a change of control clause in its bottling arrangements with Britvic ( BTVCF ), potentially removing a hurdle from the Danish brewer's path to bid for the British company. The move could pave the way for Carlsberg to raise its bid for British soft drinks maker Britvic...
PepsiCo to waive clause in bottling deal as Carlsberg eyes $3.9 billion Britvic bid
PepsiCo to waive clause in bottling deal as Carlsberg eyes $3.9 billion Britvic bid
Jun 24, 2024
(Reuters) - Carlsberg said on Monday PepsiCo has agreed to waive a change of control clause in its bottling arrangements with Britvic ( BTVCF ), potentially removing a hurdle from the Danish brewer's path to bid for the British company. The move could pave the way for Carlsberg to raise its bid for British soft drinks maker Britvic ( BTVCF...
Copyright 2023-2026 - www.financetom.com All Rights Reserved